Diseases, Free Full-Text

Colorectal cancer (CRC) is the third most common cancer worldwide. A diagnosis at early stages with enhanced screening methods is vital as metastases and recurrences increase mortality. The aim of this study was to analyze the tumor markers CEA and CA19-9 combined in correlation with diagnostics and prognosis. Therefore, 1487 patients with CRC who were diagnosed and treated between 2000 and 2015 at the University Hospital Ulm, Germany, were retrospectively evaluated. Overall and recurrence-free survival was analyzed in association with preoperative CEA and CA19-9 separately and combined and a multivariate analysis was performed. The 5-year overall survival was significantly shorter in patients with a CEA or CA19-9 level ≥200 compared to patients with an increased, but <200, or normal level (CEA: 69%/44%/7%; CA19-9: 66%/38%/8%). Patients with both tumor markers increased also showed a remarkably shorter 5-year survival rate (CEA+/CA19-9+: 23%). The multivariate analysis emphasizes these results (p-value < 0.0001). Patients with both tumor markers elevated had the shortest 5-year recurrence-free survival rate, followed by patients with either CEA or CA19-9 elevated (CEA-/CA19-9-: 79%; CEA+/CA19-9; CEA-/CA19-9+: 65%; CEA+/CA19-9+: 44%). In conclusion, measuring CEA and CA19-9 preoperatively in CRC patients is reasonable and could be useful as a prognostic factor.

Cell free DNA as a diagnostic and prognostic marker for cardiovascular diseases - ScienceDirect

RePub, Erasmus University Repository: Modeling human brain diseases using pluripotent stem cells

Pinkbook Course Book: Epidemiology of Vaccine Preventable Diseases

Report: Healthy Fossil Fuel Free World Means Re-Imagining New Clean Energy Future - The Global Climate and Health Alliance

PDF) Full Length Research Paper Observation of free range Chicken Diseases in selected Districts of North Western Amhara

Over half of known human pathogenic diseases can be aggravated by climate change

Global burden of 369 diseases and injuries in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019 - The Lancet

Childhood diseases

Diseases - Classification, Types and Causes of Diseases

Frontiers Management and Prevention Strategies for Non-communicable Diseases (NCDs) and Their Risk Factors

Global Burden of Cardiovascular Diseases and Risk Factors, 1990–2019: Update From the GBD 2019 Study - ScienceDirect